13 11 20

Information and support

  • Get informed
  • Get support
  • Cut my risk
  • Get involved
  • Research
  • BGB-A317-290-LTE1

    Acronym: 

    BGB-A317-290

    ACTRN/NCT /ethics: 

    NCT04164199

    Scientific title: 

    An Open-Label, Multicentre, Long-term Extension Study of Tislelizumab-Containing Treatment and/or Pamiparib-Containing Treatment in Patients with Advanced Malignancies

    Summary of trial and patient characteristics

    Cancer Type All cancers
    Trial Type Treatment
    Phase Phase III Tumour Stream All cancers
    Age Range 18 years and older Cancer Stage Locally Recurrent or Locally Advanced
    Sex Both Anticipated Start Date 2019-01-19
    Molecular Target Anticipated End Date 2024-12-16
    Cancer Type All cancers
    Trial Type Treatment
    Phase Phase III
    Age Range 18 years and older
    Sex Both
    Molecular Target
    Tumour Stream All cancers
    Cancer Stage Locally Recurrent or Locally Advanced
    Anticipated Start Date 2019-01-19
    Anticipated End Date 2024-12-16

    Trial Summary

    This is an open-label, multicenter, extension study to evaluate the long-term safety of tislelizumab or pamiparib given either as monotherapy or in combination with each other or with other agents in participants with advanced malignancies who participated in a prior BeiGene sponsored clinical study (parent study). For the purposes of this study, "study treatment" will refer to the investigational agents, tislelizumab and/or pamiparib. A parent study is defined as the original BeiGene sponsored clinical trial in which the participant was initially enrolled and received tislelizumab or pamiparib treatment or both (with or without other treatments).

    Lay Summary

    An Open-Label, Multicentre, Long-term Extension Study of Tislelizumab-Containing Treatment and/or Pamiparib-Containing Treatment in Patients with Advanced Malignancies

    Sponsor / Cooperative group

    Beigene

    Participating Hospitals

    Hospital Clinical Trial Coordinator Email Phone Principal Investigator Recruitment Status
    The Queen Elizabeth Hospital Pamela Cooper pamela.cooper@sa.gov.au 08 8222 6410 Dr Amanda Townsend Not Yet Recruiting